Loss of HSF1 augmented hypertrophic response of CMs to ischaemia, indicating that the reduction of HSF1 activity may promote the progression of cardiac hypertrophy and the transition to heart failure in vivo. Here, HSF1 is linked to cardiac hypertrophy.